A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant

European Journal of Immunology

Volumn 28, Issue 4, 1998, Pages 1401-1407

  Lo Man, Richard ^a   Rueda, Paloma ^b   Sedlik, Christine ^a   Deriaud, Edith ^a   Casal, Ignacio ^b   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

^b Inmunologia y Genetica Aplicada SA   (Spain)

Author keywords

Antigen processing; Cytotoxic T lymphocyte response; Parvovirus like particle; Th1 response

Indexed keywords

BREFELDIN A; CAPSID PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOHEXIMIDE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS RECOMBINANT; ANIMAL; BAGG ALBINO MOUSE; DBA MOUSE; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; TH1 CELL; VIRION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, VIRAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PARVOVIRUS; RECOMBINATION, GENETIC; TH1 CELLS; VIRION;

EID: 0031980425     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199804)28:04<1401::aid-immu1401>3.0.co;2-m     Document Type: Article

References (19)

1. Milich, D. R., T- and B-cell recognition of hepatitis B viral antigens. Immunol. Today 1988. 9: 380-386.
2. Milich, D. R., Peterson, D. L., Zheng, J., Hughes, J. L., Wirtz, R. and Schödel, F., The hepatitis nucleocapsid as a vaccine carrier moiety. Ann. N. Y. Acad. Sci. 1995. 754: 187-201.
3. Michel, M.-L., Mancini, M., Schlienger, K. and Tiollais, P., Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes. Res. Virol. 1993. 144: 263-267.
4. Griffiths, J. C., Harris, S. J., Layton, G. T., Berrie, E. L., French, T. J., Burns, N. R., Adams, S. E. and Kingsman, A. J., Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 1993. 67: 3191-3198.
5. Layton, G. T., Harris, S. J., Gearing, A. J. H., Hill-Perkins, M., Cole, J. S., Griffiths, J. C., Burns, N. R., Kingsman, A. J. and Adams, S. E., Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 1993. 51. 1097-1107.
6. Weber, J., Cheinsong-Popov, R., Callow, D., Adams, S., Patou, G., Hodgkin, K., Martin, S., Gotch, F. and Kingsman, A., Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers. Vaccine 1995. 13: 831-834.
7. Sedlik, C., Saron, M.-F., Sarraseca, J., Casal, I. and Leclerc, C., Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1997. 94: 7503-7508.
8. Sedlik, C., Sarraseca, J., Rueda, P., Leclerc, C. and Casal, I., Immunogenicity of poliovirus B and T cell epitopes presented by hybrid parvovirus particles. J. Gen. Virol. 1995. 76: 2361-2368.
9. + T cell help. J. Immunol. 1991. 147: 4069-4073.
10. Comoy, E. E., Capron, A. and Thyphronitis, G., In vivo induction of type 1 and 2 immune responses against protein antigens. Int. Immunol. 1997. 9: 523-531.
11. + T cell response induced by particulate antigen targeted to phagocytic cells. Int. Immunol. 1997. 9: 91-103.
12. Milich, D. R., Schödel, F., Hughes, J. L. and Peterson, D. L., The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J. Virol. 1997. 71: 2192-2201.
13. Schirmbeck, R., Bohm, W., Melber, K. and Reimann, J., Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 1995. 155: 4676-4684.
14. Kovacsovics-Bankowski, M. and Rock, K. L., A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995. 267: 243-246.
15. Monji, T. and Pious, D., Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells. J. Immunol. 1997. 158: 3155-3164.
16. Schirmbeck, R., Melber, K. and Reimann, J., Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 1995. 25: 1063-1070.
17. Schirmbeck, R. and Reimann, J., Empty Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation. Eur. J. Immunol. 1996. 26: 2812-2822.
18. Milich, D. R., McLachlan, A., Chisari, F. V. and Thornton, G. B., Nonoverlapping T and B cell determinants on an hepatitis B surface antigen PRE-S(2) region synthetic peptide. J. Exp. Med. 1986. 164: 532-547.
19. + T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant. Int. Immunol. 1995. 7: 45-53.